Location of Repository

Relationship between 5-fluorouracil exposure and outcome in patients receiving continuous venous infusion with or without concomitant radiotherapy

By Maud Beneton, Sophie Chapet, Hélène Blasco, Bruno Giraudeau, Michèle Boisdron-Celle, Régine Deporte-Fety, Fabrice Denis, Bérangère Narcisso, Gilles Calais and Chantal Le Guellec

Abstract

What is already known about this subjectDihydropyrimidine dehydrogenase (DPD) deficiency is currently evaluated as a means of identifying patients with a risk of toxicity during 5-fluorouracil (5-FU) treatment.Therapeutic drug monitoring (TDM) is a complementary tool already shown to be useful for doses of 1000 mg m−2 day−1.We carried out the first analysis of the concentration – effect relationships of 5-FU administered at a dose of 600 mg m−2 day−1 with concomitant radiotherapy.What this study addsNo relationship was found between exposure and toxicity for 5-FU administered at a dose of 600 mg m−2 day−1 with concomitant radiotherapy.The use of TDM to improve tolerance to this treatment protocol is not supported by our data.This study confirms the existence of an exposure – toxicity relationship for a dose of 1000 mg m−2 day−1 and has developed a simplified sampling strategy to make TDM easier to implement with this dose schedule

Topics: Pharmacokinetics and Pharmacodynamics
Publisher: Blackwell Science Inc
OAI identifier: oai:pubmedcentral.nih.gov:2203258
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.